Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

NCT00449280 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Sorafenib
DRUG: Rapamycin
DRUG: Rapamycin

Sponsor

University of Chicago

Collaborators

[object Object]